Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Osteosarcoma × penpulimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Pheochromocytoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Paraganglioma, Extra-Adrenal 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma Metastatic 1 Osteosarcoma 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Gynecological Cancer 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Esophageal Squamous Cell Carcinoma 1 Digestive System Diseases 1 Carcinoma 1 Breast Neoplasms 1 Breast Neoplasm Female 1

Interventions

Ifosfamide 14 Doxorubicin 11 Methotrexate 10 Cisplatin 9 Filgrastim 8 Cyclophosphamide 8 Etoposide 7 Magnetic Resonance Spectroscopy 6 apatinib 5 X-Rays 5 Specimen Handling 5 Sirolimus 5 Phantoms, Imaging 5 Nivolumab 5 Neoadjuvant Therapy 5 Leucovorin 5 Gemcitabine 5 Radiotherapy 4 Nuclear Medicine Department, Hospital 4 Drug Therapy 4 Docetaxel 4 Biopsy 4 regorafenib 3 palbociclib 3 olaparib 3 mifamurtide 3 fludarabine 3 cixutumumab 3 camrelizumab 3 cabozantinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06114225 2023-11-02

PROMIS

Ruijin Hospital

Phase 2 Recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡